Table of Contents Title of each class Trading Symbol(s) Name of exchange on which registered DOCS The New York Stock Exchange Class A common stock, $0.001 par value per share UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________________________________________________________ FORM 10-Q _________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPO ...

Exhibit 99.1 Doximity Announces Fiscal 2025 Second Quarter Financial Results Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year SAN FRANCISCO, Calif., November 7, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescr ...

In the latest trading session, Doximity (DOCS) closed at $41.88, marking a +1.11% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.16%. Meanwhile, the Dow experienced a drop of 0.37%, and the technology-dominated Nasdaq saw an increase of 0.78%. Shares of the medical social networking site have depreciated by 4.93% over the course of the past month, underperforming the Medical sector's loss of 4.09% and the S&P 500's gain of 1.67%. Analysts and investors alike will be keeping a c ...

Doximity (DOCS) closed at $41.42 in the latest trading session, marking a -1.76% move from the prior day. This change lagged the S&P 500's daily loss of 0.92%. At the same time, the Dow lost 0.96%, and the tech-heavy Nasdaq lost 1.6%.The medical social networking site's shares have seen an increase of 1.91% over the last month, surpassing the Medical sector's loss of 4.16% and falling behind the S&P 500's gain of 2.68%.The upcoming earnings release of Doximity will be of great interest to investors. The com ...

The Medical Services sector is experiencing significant evolution driven by innovation and digital applications. Growing demand for remote treatment has led to a tremendous upsurge in digital healthcare options over the past few years. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics. According to a recent Mordor Intelligence report, the global healthcare analytics mark ...

Doximity (DOCS) ended the recent trading session at $40.88, demonstrating a +0.62% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.19%. At the same time, the Dow added 0.09%, and the tech-heavy Nasdaq lost 0.36%. The medical social networking site's shares have seen an increase of 12.05% over the last month, surpassing the Medical sector's gain of 1.44% and the S&P 500's gain of 2.06%. The investment community will be closely monitoring the performance of Doxim ...

Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Doximity (DOCS) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank emphasizes companies with positive estim ...

It's a welcome sight for shareholders who haven't had much to rejoice about lately. What a difference a day can make. Until Aug. 8, shares of Doximity (DOCS 0.69%), a healthcare-focused networking platform, were in the red for the year. However, on Aug. 9, the company's stock skyrocketed by more than 33%, making its year-to-date performance better than that of the broader market. As investors might guess, Doximity's gains had something to do with its latest quarterly report, but even after this jump, shares ...

Morsa Images Pondering the issue of sustainable growth Earlier this month, Doximity, whose shares had been languishing in investor purgatory for most of 2024 reported its results for fiscal Q1 2025. The results were significantly better than had been anticipated with revenues of $127 million compared to the prior forecast of $120 million, and adjusted EBITDA of $66 million compared to a prior forecast of $56 million. Year over year revenue growth was 17% while the adjusted EBITDA rose by 42% and the adjuste ...

Doximity Today DOCS Doximity $36.21 +0.18 (+0.50%) 52-Week Range $19.71 ▼ $37.25 P/E Ratio 50.29 Price Target $31.27 Add to Watchlist Doximity Inc. NASDAQ: DOCS is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc. NASDAQ: META Facebook. The platform enables physicians to connect with their colleagues to collaborate on patient treatments and research. It also provides the latest medical news and research and provides access to various career tools. Do ...